ERXI WU to Neoplastic Stem Cells
This is a "connection" page, showing publications ERXI WU has written about Neoplastic Stem Cells.
Connection Strength
1.580
-
Trailblazing perspectives on targeting breast cancer stem cells. Pharmacol Ther. 2021 07; 223:107800.
Score: 0.568
-
Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells. J Am Chem Soc. 2019 02 27; 141(8):3613-3622.
Score: 0.498
-
Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters. Cell Mol Biol Lett. 2025 Feb 24; 30(1):23.
Score: 0.189
-
Salinomycin as a potent anticancer stem cell agent: State of the art and future directions. Med Res Rev. 2022 05; 42(3):1037-1063.
Score: 0.151
-
Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. Int J Oncol. 2019 01; 54(1):98-110.
Score: 0.122
-
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2019 Jan; 52(1):e12514.
Score: 0.030
-
Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-?B pathways with novel theanine derivatives. Oncotarget. 2014 Sep 30; 5(18):8528-43.
Score: 0.023